Early Two-dose Measles Vaccination Trial
Measles
About this trial
This is an interventional prevention trial for Measles focused on measuring Non-specific effects of vaccines, Infant mortality, Child mortality, Mortality, Morbidity, Diphtheria-tetanus-pertussis vaccine, Measles vaccine, Measles, Immunisation, Low income country, Guinea-Bissau, Bandim Health Project, Immunology
Eligibility Criteria
Inclusion Criteria: Infants of 4½ months of age registered in the Bandim Health Project registration system and currently living in the Bandim Health Project areas: Bandim I, Bandim II, Belem, Mindará and Cuntum; and who received all three diphtheria-tetanus-pertussis vaccinations at least 4 weeks before enrollment Exclusion Criteria: Severe illness requiring immediate hospitalisation
Sites / Locations
- Bandim Health Project
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
1
2
3
Standard titre Edmonston-Zagreb measles vaccine at 4½ and 9 months of age
Standard titre Schwarz measles vaccine at 9 months of age
Standard titre Edmonston-Zagreb measles vaccine at 9 months of age